OncLiveDr. Perales on Treatment With Approved CAR T-Cell TherapyOncLiveMiguel-Angel Perales, MD, Deputy Chief, Adult Bone Marrow Transplant Service, director, Adult Bone Marrow Transplantation Fellowship Program, Memorial Sloan Kettering Cancer Center,… Continue reading
Popular Science |
China might be winning the CRISPR race, but we have the FDA
Popular Science But how did China edge out the United States to become the first to use CRISPR in humans? American researchers were, after all, the ones who discovered the techniques’ ability to tweak and alter DNA. But as the Wall Street Journal points out, America … China’s gene editing targets HIV, leukemiaWND.com |
Epidermolysis Bullosa News |
Abeona’s Gene Therapy EB-101 Receives FDA’s Regenerative Medicine Advanced Therapy Designation
Epidermolysis Bullosa News Abeona Therapeutics’ EB-101, a gene therapy in development for patients with recessive dystrophic epidermolysis bullosa (RDEB), has received the regenerative medicine advanced therapy (RMAT) designation by the U.S. Food and Drug Administration (FDA … Abeona Gene Therapy Gains FDA Regenerative Medicine DesignationPharmaceutical Processing FDA grants RMAT designation for Abeona’s gene therapy for epidermolysis bullosaEPM Magazine |